Perbedaan Diagnos Laboratorium Utama Tbk. dan Suparma Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Suparma Tbk. diperdagangkan di Rp168 (kapitalisasi pasar 697,05 M, volume 24 jam 339,9 rb). Perbedaan utamanya: Suparma Tbk. jauh lebih besar — sekitar 2,2× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Diagnos Laboratorium Utama Tbk. lebih aktif diperdagangkan (963,6 rb vs 339,9 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | SPMA | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 697,05 M |
Volume | 963,6 rb | 339,9 rb |
Lot | 9,64 rb | 3,4 rb |
Perputaran | 217,67 jt | 57,35 jt |
Harga Rata-rata | 225,89 | 168,71 |
Nilai Transaksi | 217,67 jt | 57,35 jt |
Harga Ekuilibrium Indikatif | 226 | 168 |
Volume Ekuilibrium Indikatif | 1 rb | 2 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Selengkapnya di halaman SPMA →